CheckMyRecalls

The Harvard Drug Group LLC recalls Midodrine Hydrochloride Tablets

Published
11 Mar 2026
Units affected
8892 cartons
Agency
FDA
Country
United States

The hazard

Defective container; inadequately sealed blister packaging.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06.

Brand / company
The Harvard Drug Group LLC
Codes / lots
Lot # N02640, Exp Date: 08/2027
Distribution
Nationwide US.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 11 Mar 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.